Beximco Pharmaceuticals Limited (“BPL” or “the Company"; AIM Symbol: BXP), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces its un-audited results for the six months ended June 30, 2014.
Highlights
Half year financial highlights
• Net sales increased by 7.2% to Bangladesh Taka (“BDT”) 5,322.2m / £40.2m (2013: BDT 4,966.4m / £42m)
o Domestic sales increased 10.0% to BDT 5,099.2m / £38.5m (H1 2013: BDT 4,634.9m / £39.2m)
• Profit before tax increased by 6.6% to BDT 1,018.5m / £7.69m (H1 2013: BDT 955.6m /£8.1m)
For full access, please click here.
Help employers find you! Check out all the jobs and post your resume.
